Biodesix (BDSX) PT Raised to $27 at Canaccord Jun 18, 2026 06:57AM
H.C. Wainwright Starts Biodesix (BDSX) at Buy Jun 15, 2026 06:14AM
Biodesix (BDSX) PT Raised to $22 at Canaccord May 5, 2026 07:50AM
Biodesix Inc. (BDSX) Misses Q1 EPS by 81c May 4, 2026 05:10PM
Biodesix publishes lung nodule biomarker validation study on 1,100 patients Mar 20, 2026 08:06AM


Mar 2, 2026 04:57AM Canaccord Reiterates Buy Rating on Biodesix (BDSX)
Feb 27, 2026 01:03AM William Blair Upgrades Biodesix (BDSX) to Outperform
Feb 26, 2026 05:18PM Biodesix Inc. (BDSX) Misses Q4 EPS by 49c
Jan 13, 2026 06:30AM Canaccord Genuity Reiterates Buy Rating on Biodesix (BDSX)
Jan 12, 2026 06:02AM Biodesix reports preliminary Q4 revenue of $28.8 million
Nov 4, 2025 03:19AM Canaccord Genuity Reiterates Buy Rating on Biodesix (BDSX)
Nov 3, 2025 04:23PM Biodesix Inc. (BDSX) Misses Q3 EPS by 110c
Sep 19, 2025 03:34AM Biodesix (BDSX) PT Lowered to $20 at Canaccord Genuity
Aug 7, 2025 04:16PM Biodesix Inc. (BDSX) Misses Q2 EPS by 1c ; Offers Guidance
May 21, 2025 12:38PM Biodesix (BDSX) PT Lowered to $2 at Scotiabank
May 15, 2025 01:12AM Biodesix Inc. (BDSX) Misses Q1 EPS by 1c ; Offers Guidance
May 14, 2025 09:15AM Biodesix (BDSX) PT Lowered to $2 at TD Cowen; '1Q Miss & Guide Down as Sales Force Headcount Lags'
May 14, 2025 05:03AM William Blair Downgrades Biodesix (BDSX) to Market Perform
May 14, 2025 04:33AM Biodesix (BDSX) PT Lowered to $1.50 at Canaccord Genuity
Mar 3, 2025 04:29PM Biodesix Inc. (BDSX) Tops Q4 EPS by 1c
Nov 1, 2024 06:15AM Biodesix Inc. (BDSX) Reports In-Line Q3 EPS
Aug 7, 2024 04:17PM Biodesix Inc. (BDSX) Tops Q2 EPS by 1c ; Offers Guidance
Jul 26, 2024 09:09AM Craig-Hallum Starts Biodesix (BDSX) at Buy